Why the study?
Consumer-facing digital health tools can detect and monitor AF, but evidence demonstrating their diagnostic utility and how they should be used in general populations without known AF remains limited.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Turchioe et al. (2023) conducted an editorial in Atrial fibrillation (n=14,000). AliveCor Kardia single-lead ECG screening vs. Cardiologist overread (or usual care in parent VITAL-AF trial) was evaluated on Diagnostic accuracy of AliveCor Kardia algorithm for atrial fibrillation detection.
Synapse has enriched 10 related papers. Consider them for comparative context: